Atrion Corp
NASDAQ:ATRI
Atrion Corp
Research & Development
Atrion Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Atrion Corp
NASDAQ:ATRI
|
Research & Development
-$6.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Research & Development
-$62.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Research & Development
-$88.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-18%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$369.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-20%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$165.2m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-26%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Research & Development
-$96m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-9%
|
|
Atrion Corp
Glance View
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 667 full-time employees. The firm's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. The company has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. The firm's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. The company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.
See Also
What is Atrion Corp's Research & Development?
Research & Development
-6.4m
USD
Based on the financial report for Jun 30, 2024, Atrion Corp's Research & Development amounts to -6.4m USD.
What is Atrion Corp's Research & Development growth rate?
Research & Development CAGR 10Y
-4%
Over the last year, the Research & Development growth was -11%. The average annual Research & Development growth rates for Atrion Corp have been -5% over the past three years , -6% over the past five years , and -4% over the past ten years .
